Shintaro Iwata1, Kosuke Uehara2, Koichi Ogura3,4, Toru Akiyama5, Yusuke Shinoda6, Tsukasa Yonemoto1, Akira Kawai7. 1. Division of Orthopedic Surgery, Chiba Cancer Center, Chiba, Japan. 2. Department of Orthopaedic Surgery, The University of Tokyo Hospital, Tokyo, Japan. 3. Department of Orthopaedic Surgery, The University of Tokyo Hospital, Tokyo, Japan. ogura-tky@umin.ac.jp. 4. Department of Musculoskeletal Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. ogura-tky@umin.ac.jp. 5. Department of Orthopaedic Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Japan. 6. Department of Rehabilitation Medicine, The University of Tokyo, Tokyo, Japan. 7. Department of Musculoskeletal Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Abstract
BACKGROUND: The Musculoskeletal Tumor Society (MSTS) scoring system is a widely used functional evaluation tool for patients treated for musculoskeletal tumors. Although the MSTS scoring system has been validated in English and Brazilian Portuguese, a Japanese version of the MSTS scoring system has not yet been validated. QUESTIONS/ PURPOSE: We sought to determine whether a Japanese-language translation of the MSTS scoring system for the lower extremity had (1) sufficient reliability and internal consistency, (2) adequate construct validity, and (3) reasonable criterion validity compared with the Toronto Extremity Salvage Score (TESS) and SF-36 using psychometric analysis. METHODS: The Japanese version of the MSTS scoring system was developed using accepted guidelines, which included translation of the English version of the MSTS into Japanese by five native Japanese bilingual musculoskeletal oncology surgeons and integrated into one document. One hundred patients with a diagnosis of intermediate or malignant bone or soft tissue tumors located in the lower extremity and who had undergone tumor resection with or without reconstruction or amputation participated in this study. Reliability was evaluated by test-retest analysis, and internal consistency was established by Cronbach's alpha coefficient. Construct validity was evaluated using the principal factor analysis and Akaike information criterion network. Criterion validity was evaluated by comparing the MSTS scoring system with the TESS and SF-36. RESULTS: Test-retest analysis showed a high intraclass correlation coefficient (0.92; 95% CI, 0.88-0.95), indicating high reliability of the Japanese version of the MSTS scoring system, although a considerable ceiling effect was observed, with 23 patients (23%) given the maximum score. Cronbach's alpha coefficient was 0.87 (95% CI, 0.82-0.90), suggesting a high level of internal consistency. Factor analysis revealed that all items had high loading values and communalities; we identified a central role for the items "walking" and "gait" according to the Akaike information criterion network. The total MSTS score was correlated with that of the TESS (r = 0.81; 95% CI, 0.73-0.87; p < 0.001) and the physical component summary and physical functioning of the SF-36. CONCLUSIONS: The Japanese-language translation of the MSTS scoring system for the lower extremity has sufficient reliability and reasonable validity. Nevertheless, the observation of a ceiling effect suggests poor ability of this system to discriminate from among patients who have a high level of function.
BACKGROUND: The Musculoskeletal Tumor Society (MSTS) scoring system is a widely used functional evaluation tool for patients treated for musculoskeletal tumors. Although the MSTS scoring system has been validated in English and Brazilian Portuguese, a Japanese version of the MSTS scoring system has not yet been validated. QUESTIONS/ PURPOSE: We sought to determine whether a Japanese-language translation of the MSTS scoring system for the lower extremity had (1) sufficient reliability and internal consistency, (2) adequate construct validity, and (3) reasonable criterion validity compared with the Toronto Extremity Salvage Score (TESS) and SF-36 using psychometric analysis. METHODS: The Japanese version of the MSTS scoring system was developed using accepted guidelines, which included translation of the English version of the MSTS into Japanese by five native Japanese bilingual musculoskeletal oncology surgeons and integrated into one document. One hundred patients with a diagnosis of intermediate or malignant bone or soft tissue tumors located in the lower extremity and who had undergone tumor resection with or without reconstruction or amputation participated in this study. Reliability was evaluated by test-retest analysis, and internal consistency was established by Cronbach's alpha coefficient. Construct validity was evaluated using the principal factor analysis and Akaike information criterion network. Criterion validity was evaluated by comparing the MSTS scoring system with the TESS and SF-36. RESULTS: Test-retest analysis showed a high intraclass correlation coefficient (0.92; 95% CI, 0.88-0.95), indicating high reliability of the Japanese version of the MSTS scoring system, although a considerable ceiling effect was observed, with 23 patients (23%) given the maximum score. Cronbach's alpha coefficient was 0.87 (95% CI, 0.82-0.90), suggesting a high level of internal consistency. Factor analysis revealed that all items had high loading values and communalities; we identified a central role for the items "walking" and "gait" according to the Akaike information criterion network. The total MSTS score was correlated with that of the TESS (r = 0.81; 95% CI, 0.73-0.87; p < 0.001) and the physical component summary and physical functioning of the SF-36. CONCLUSIONS: The Japanese-language translation of the MSTS scoring system for the lower extremity has sufficient reliability and reasonable validity. Nevertheless, the observation of a ceiling effect suggests poor ability of this system to discriminate from among patients who have a high level of function.
Authors: Caroline B Terwee; Sandra D M Bot; Michael R de Boer; Daniëlle A W M van der Windt; Dirk L Knol; Joost Dekker; Lex M Bouter; Henrica C W de Vet Journal: J Clin Epidemiol Date: 2006-08-24 Impact factor: 6.437
Authors: Jill P Ginsberg; Shesh N Rai; Claire A Carlson; Anna T Meadows; Pamela S Hinds; Elena M Spearing; Lijun Zhang; Lulie Callaway; Michael D Neel; Bhaskar N Rao; Victoria G Marchese Journal: Pediatr Blood Cancer Date: 2007-12 Impact factor: 3.167
Authors: Teun Teunis; Sjoerd P F T Nota; Francis J Hornicek; Joseph H Schwab; Santiago A Lozano-Calderón Journal: Clin Orthop Relat Res Date: 2014-01-28 Impact factor: 4.176
Authors: Sang Hoon Lee; Dong Joon Kim; Joo Han Oh; Hyuk Soo Han; Kwang Hyun Yoo; Han Soo Kim Journal: Clin Orthop Relat Res Date: 2003-06 Impact factor: 4.176
Authors: Daniel Cesar Seguel Rebolledo; João Ricardo Nickenig Vissoci; Ricardo Pietrobon; Olavo Pires de Camargo; Andre Mathias Baptista Journal: Clin Orthop Relat Res Date: 2013-08-06 Impact factor: 4.176
Authors: Koichi Ogura; Mohamed A Yakoub; Alexander B Christ; Tomohiro Fujiwara; Zarko Nikolic; Patrick J Boland; Edward A Athanasian; John H Healey Journal: J Shoulder Elbow Surg Date: 2021-01-20 Impact factor: 3.507
Authors: Koichi Ogura; Mohamed A Yakoub; Alexander B Christ; Tomohiro Fujiwara; Zarko Nikolic; Patrick J Boland; John H Healey Journal: Clin Orthop Relat Res Date: 2020-09 Impact factor: 4.755
Authors: Ioanna K Bolia; Olga D Savvidou; Hyunwoo P Kang; Nikolaos Chatzichristodoulou; Panayiotis D Megaloikonomos; Evanthia Mitsiokapa; Andreas F Mavrogenis; Panayiotis J Papagelopoulos Journal: Eur J Orthop Surg Traumatol Date: 2021-03-15